Method for treating an inflammation or lesion caused by a virus
View Patent ↗A method for treating an inflammation or lesion caused by herpesvirus, comprising topically applying to said inflammation or lesion a composition consisting essentially of a C1 to C3 monohydroxy alcohol or a C2 to C4 diol and a sufficient amount of an acid to adjust the pH of the composition to below 4.6. Topical administration of the composition is preferred and is effective in treating lesions associated infections by viruses such as herpes simplex. Nasal deliverable forms are effective in treating symptoms due to viruses that cause the common cold. Pharmaceutical compositions for use in the present method are provided.
1. A method of inactivating an enveloped virus on the skin of a human, comprising applying to an area of the skin infected with said virus a virucidally effective amount of a composition whose active ingredients consist of a C1-C3 alcohol or a C2-C4 diol in a concentration between about 0.2% and 12.5% by volume of said composition, and a sufficient amount of an acid to adjust the pH of the composition to 4.6 or less.
2. The method of claim 1 , wherein said alcohol is selected from the group consisting of methanol, ethanol, 1-propanol, and 2-propanol.
3. The method of claim 1 , wherein said alcohol is selected from the group consisting of 2,3-butanediol, 1,2-butanediol, 1,3-butanediol, and 1,4-butanediol.
4. The method of claim 2 , wherein said alcohol is ethanol.
5. The method of claim 1 , wherein said acid is an organic acid.
6. The method of claim 5 , wherein said organic acid selected from the group consisting of glycolic acid, lactic acid, succinic acid, malic acid, citric acid and acetic acid.
7. The method of claim 1 , wherein said acid is an inorganic acid.
8. The method of claim 7 , wherein said acid is hydrochloric acid.
9. The method of claim 1 , wherein the pH of said composition is 2.45.
10. The method of claim 1 , wherein said virus is a member of the Herpesviridae family.
11. The method of claim 10 , wherein said virus is herpes simplex 1.
12. The method of claim 10 , wherein said virus is herpes simplex 2.
13. The method of claim 10 , wherein said virus is Varicella-zoster virus.
14. The method of claim 10 , wherein said composition is applied topically to reduce or inhibit lesions in an animal or human suffering from an infection by said virus.
15. The method of claim 1 , wherein said composition is a topical preparation selected from the group consisting of a tincture, gel, ointment, cream, salve, lotion, lip balm, foam.
16. A method of inactivating a virus on the skin of a human, comprising applying to an area of the skin infected with said virus a virucidally effective amount of a composition, wherein the active ingredients of said composition consist of a C1, a C2, or a C3 alcohol or a C2, C3, or C4 diol in a concentration between about 0.2% and 12.5% by volume of said composition, and a sufficient amount of an acid to adjust the pH of the composition to 4.6 or less.
17. The method of claim 16 , wherein said alcohol is selected from the group consisting of methanol, ethanol, 1-propanol, and 2-propanol.
18. The method of claim 16 , wherein said alcohol is selected from the group consisting of 2,3-butanediol, 1,2-butanediol, 1,3-butanediol, and 1,4-butanediol.
19. The method of claim 17 , wherein said alcohol is ethanol.
20. The method of claim 16 , wherein said acid is an organic acid.
21. The method of claim 20 , wherein said organic acid selected from the group consisting of glycolic acid, lactic acid, succinic acid, malic acid, citric acid and acetic acid.
22. The method of claim 16 , wherein said acid is an inorganic acid.
23. The method of claim 22 , wherein said acid is hydrochloric acid.
24. The method of claim 16 , wherein the pH of said composition is 2.45.
25. The method of claim 16 , wherein said virus resides in the dermis or epidermis of a human or animal infected by said virus.
26. The method of claim 16 , wherein said composition is applied topically to reduce or inhibit lesions in an animal or human suffering from an infection by said virus.
27. The method of claim 16 , wherein said virus is a member of the Herpesviridae family.
28. The method of claim 27 , wherein said virus is herpes simplex 1.
29. The method of claim 27 , wherein said virus is herpes simplex 2.
30. The method of claim 16 , wherein said virus is Varicella-zoster virus.
31. The method of claim 16 , wherein said virus is a member of the Poxviridae family.
32. The method of claim 31 , wherein said virus is molluscum contagiosum.
33. The method of claim 16 , wherein said virus is selected from the group consisting of rhinoviruses, adenoviruses, enteroviruses, cornoviruses, respiratory syncytial viruses, influenza viruses and parainfluenza viruses.
34. The method of claim 16 , wherein said composition is a preparation selected from the group consisting of a tincture, gel, ointment, cream, salve, lotion, lip balm, foam, spray and aerosol.
35. A method of inactivating a virus on the skin of a human, said method comprising applying to an area of skin infected with said virus a virucidally effective amount of a composition wherein the active ingredients of said composition consist of an alcohol selected from the group consisting of methanol, ethanol, 1-propanal, 2-propanol, 2,3-butanediol, 1,2-butanediol, 1,3-butanediol, and 1,4-butanediol where said alcohol is present in a concentration between about 0.2% and 12.5% by volume of said composition, and a sufficient amount of an acid to adjust the pH of the composition to 4.6 or less, wherein said acid selected from the group consisting of glycolic acid, lactic acid, succinic acid, malic acid, citric acid, acetic acid, and hydrochloric acid.
36. The method of claim 35 , wherein the pH of said composition is 2.45.
37. The method of claim 35 , wherein the concentration of said alcohol in said composition is between about 0.2% and 12.5% by volume.
38. The method of claim 35 , wherein said composition is applied topically to reduce or inhibit lesions in an animal or human suffering from an infection by said virus.
39. The method of claim 35 , wherein said virus resides in the dermis or epidermis of a human or animal infected by said virus.
40. The method of claim 35 , wherein said virus is a member of the Herpesviridae family.
41. The method of claim 40 , wherein said virus is herpes simplex 1.
42. The method of claim 40 , wherein said virus is herpes simplex 2.
43. The method of claim 40 , wherein said virus is Varicella-zoster virus.
44. The method of claim 35 , wherein said virus is a member of the Poxviridae family.
45. The method of claim 44 , wherein said virus is molluscum contagiosum.
46. The method of claim 35 , wherein said virus is selected from the group consisting of rhinoviruses, adenoviruses, enteroviruses, comoviruses, respiratory syncytial viruses, influenza viruses and parainfluenza viruses.